The AI Slop Era: 6 Unanswered Questions for 2026
The AI industry is in an awkward phase, defined by low-quality “slop” and massive hype. But key questions about data, regulation, and profitability remain stubbornly unanswered as we head into 2026.
The AI industry is in an awkward phase, defined by low-quality “slop” and massive hype. But key questions about data, regulation, and profitability remain stubbornly unanswered as we head into 2026.
In the race for AI inference dominance, a new report highlights a staggering performance gap. NVIDIA’s Blackwell-based GB200 NVL72 racks are shown to massively outperform AMD’s current best, reshaping the economics of running large AI models.
According to TechRadar, 2026 will be the year AI tries to blend into the background of daily life. ChatGPT aims to become a proactive household organizer, while Google Search will fully pivot to AI-first results, and a backlash against synthetic content will make “AI-free” a new status symbol.
While everyone focused on Nvidia’s GPUs, the real bottleneck in the AI boom turned out to be memory. Kioxia Holdings, a maker of NAND flash chips, rode that demand to become 2025’s top-performing stock. Its story is a lesson in what really powers artificial intelligence.
According to PYMNTS.com, CFOs are shifting from reactive financial management to predictive intelligence. Their 2025 resolutions focus on consolidating fragmented payments data, integrating new payment ecosystems, and using AI as infrastructure to turn data into a strategic asset for better cash flo
A new wave of AI is automating the entire conversion rate optimization process. Startups like Moonshot AI are using it to run tests and implement changes autonomously, claiming massive revenue lifts for brands.
A new regulatory push in China aims to protect children from AI chatbots, while Octopus Energy’s tech platform Kraken secures a massive valuation. Meanwhile, Tesla faces more than just Musk-related headwinds.
According to a new report, Tesla’s much-hyped robotaxi program is a tiny operation with major problems. While Elon Musk promised millions of autonomous cars, the reality is about 30 supervised cabs in one city, struggling with basic safety and traffic laws.
Insilico Medicine, an AI-powered drug discovery company, saw its shares surge nearly 25% in its Hong Kong IPO. The listing, backed by giants like Eli Lilly and Tencent, values the firm at over $2 billion. Now, it has to prove its technology can actually get a drug to market.
CES 2026 is shaping up to be an AI hardware extravaganza. Companies are pushing everything from AI-powered smart glasses to humanoid robots, but the gap between flashy demos and real-world usefulness remains a huge challenge.